Puma Biotechnology (PBYI) - 5 Price Charts 2012-2023 (History)
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict - Los Angeles Business Journal
Articles with Puma Biotechnology
Puma Biotechnology Reports Third Quarter 2022 Financial Results | Business Wire
Puma Biotechnology - Crunchbase Company Profile & Funding
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Biotechnology and Pierre Fabre Enter into Exclusive License Agreement to Develop and Commercialize NERLYNX® (neratinib) in Europe | Business Wire
Former Puma Biotechnology exec is accused of making $1.2 million from insider trading - Los Angeles Times
Exhibitor Puma Biotechnology 11-6 - Scripps CME Connection
Puma Biotechnology reports interim SUMMIT results for neratinib | Drug Discovery News
Puma Biotech plunges on drug side effects
Puma Biotechnology Surging
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Biotechnology
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com
Puma Biotechnology
Puma Biotechnology
Puma Biotechnology
Puma Biotechnology Third Quarter 2022 Earnings: Beats Expectations
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Can Puma Biotechnology Inc (PBYI) Stock Rise to the Top of Healthcare Sector Tuesday?
